Video: Every Case Tells a Story| Webinar: ACR/CHEST ILD Guidelines in Practice

An official publication of the ACR and the ARP serving rheumatologists and rheumatology professionals

  • Conditions
    • Axial Spondyloarthritis
    • Gout and Crystalline Arthritis
    • Myositis
    • Osteoarthritis and Bone Disorders
    • Pain Syndromes
    • Pediatric Conditions
    • Psoriatic Arthritis
    • Rheumatoid Arthritis
    • Sjögren’s Disease
    • Systemic Lupus Erythematosus
    • Systemic Sclerosis
    • Vasculitis
    • Other Rheumatic Conditions
  • FocusRheum
    • ANCA-Associated Vasculitis
    • Axial Spondyloarthritis
    • Gout
    • Psoriatic Arthritis
    • Rheumatoid Arthritis
    • Systemic Lupus Erythematosus
  • Guidance
    • Clinical Criteria/Guidelines
    • Ethics
    • Legal Updates
    • Legislation & Advocacy
    • Meeting Reports
      • ACR Convergence
      • Other ACR meetings
      • EULAR/Other
    • Research Rheum
  • Drug Updates
    • Analgesics
    • Biologics/DMARDs
  • Practice Support
    • Billing/Coding
    • EMRs
    • Facility
    • Insurance
    • QA/QI
    • Technology
    • Workforce
  • Opinion
    • Patient Perspective
    • Profiles
    • Rheuminations
      • Video
    • Speak Out Rheum
  • Career
    • ACR ExamRheum
    • Awards
    • Career Development
  • ACR
    • ACR Home
    • ACR Convergence
    • ACR Guidelines
    • Journals
      • ACR Open Rheumatology
      • Arthritis & Rheumatology
      • Arthritis Care & Research
    • From the College
    • Events/CME
    • President’s Perspective
  • Search

Guidance

Subcategories:Clinical Criteria/GuidelinesEthicsLegal UpdatesLegislation & AdvocacyMeeting ReportsResearch Rheum

Figure 2: High-resolution computed tomography showed evidence of interstitial lung disease.

High-resolution computed tomography shows evidence of ILD.

The ACR/CHEST ILD Guidelines in Practice, a video
In collaboration with the American College of Chest Physicians, the ACR released two new comprehensive guidelines aimed at improving the screening, monitoring, and treatment of patients with interstitial lung disease (ILD) secondary to systemic autoimmune rheumatic diseases (SARDs). Recently, Sindhu R. Johnson, MD, PhD, professor of medicine at the University of Toronto, Canada, director of the Toronto Scleroderma Program and principal investigator for the guideline, and Elana J. Bernstein, MD, MSc, Florence Irving associate professor of medicine in the Division of Rheumatology at Columbia University, New York City, and co-first author, presented a webinar to talk about how the guidelines were developed and present some of the recommendations and their rationale: Watch the recording now!

 

EULAR 2013: Drugs New and Old Could Treat Spondylarthropies

Thomas R. Collins  |  September 1, 2013

Nonsteroidal anti-inflammatory drugs (NSAIDs) might still have a role in treating axial spondylarthritis, but other drugs, therapies are being explored

EULAR 2013: Researchers Make Inroads in Treatment of Osteoarthritis

Thomas R. Collins  |  September 1, 2013

Experts discuss evidence-based benefits of knee joint distraction and the progress being made in harnessing the effects of stem cells

EULAR 2013: Tips for Managing Peripheral Neuropathy in Rheumatic Disease

Thomas R. Collins  |  September 1, 2013

How to determine which tests to order, how to interpret them, and how to decide on the right treatment course

Rheumatology Research Foundation Announces 2013 Awards and Grants Recipients

Staff  |  September 1, 2013

The Foundation names winners of education and training awards, career development research awards, and disease-targeted research grants

Why I Advocate for Arthritis: A Rheumatologist’s Perspective

Chris Morris, MD  |  September 1, 2013

Chris Morris, MD, on why lobbying Congress is critical to maintain physicians’ ability to provide quality care to rheumatology patients

ACR Research Conferences to Focus on Rheumatic Diseases

Staff  |  September 1, 2013

The ACR’s Basic Research Conference and Clinical Research Conference on October 25–26 to feature new perspectives on development of rheumatoid arthritis, lupus, and vasulitis, and review current thinking on preclinical rheumatic disease

EULAR 2013: Emerging Imaging Methods in Spondylarthritis Have Advantages and Flaws

Thomas R. Collins  |  September 1, 2013

New technologies from diffusion-weighted imaging to ultrasonography are being studied and refined, but much is yet to be understood

EULAR 2013: Research Hints at Risk Factors for Rheumatoid Arthritis

Thomas R. Collins  |  September 1, 2013

Studies point to involvement of anti-CCP antibodies and citrullinated targets in the lungs and joints in the development of RA, and suggest an early therapeutic window for prevention

American College of Rheumatology Backs Bill to Prevent Cuts to Infusion Reimbursement

Richard Quinn  |  August 21, 2013

The ACR has endorsed a proposed law that would exempt physician-administered drugs from future Medicare sequestration. (posted Aug. 21, 2013)

ACR 2013 State-of-the-Art Clinical Symposium: The Challenge of Treating Low Back Pain

Kathy Holliman  |  August 1, 2013

With no single therapy effective for chronic low back pain, physicians must try multiple therapeutic approaches, nonsurgical options

  • « Previous Page
  • 1
  • …
  • 238
  • 239
  • 240
  • 241
  • 242
  • …
  • 308
  • Next Page »
  • About Us
  • Meet the Editors
  • Issue Archives
  • Contribute
  • Advertise
  • Contact Us
  • Copyright © 2025 by John Wiley & Sons, Inc. All rights reserved, including rights for text and data mining and training of artificial technologies or similar technologies. ISSN 1931-3268 (print). ISSN 1931-3209 (online).
  • DEI Statement
  • Privacy Policy
  • Terms of Use
  • Cookie Preferences